ATXI Insider Trading Activity and SEC Form 4 Filings
ATXI insider trading summary
No open-market insider purchases or sales of Avenue Therapeutics, Inc. (ATXI) have been reported on SEC Form 4 in the past 12 months.
Latest ATXI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 2, 2024 | Neil Herskowitz | Director | Sell | $46 (23 @ $2.00) |
| Nov 5, 2024 | Jay D Kranzler | Director | Sell | $137 (61 @ $2.24) |
| Sep 30, 2024 | Jay D Kranzler | Director | Buy | $1K (497 @ $2.50) |
| Sep 27, 2024 | Jay D Kranzler | Director | Buy | $7 (3 @ $2.40) |
| Dec 11, 2023 | Robert L Davidow | 10% Owner | Sell | $18K (128,000 @ $0.14) |
| Dec 11, 2023 | Robert L Davidow | 10% Owner | Sell | $9K (61,000 @ $0.14) |
| Dec 11, 2023 | Robert L Davidow | 10% Owner | Sell | $3K (20,000 @ $0.14) |
| Dec 11, 2023 | Robert L Davidow | 10% Owner | Sell | $18K (126,000 @ $0.14) |
| Dec 11, 2023 | Robert L Davidow | 10% Owner | Sell | $3K (18,000 @ $0.15) |
| Dec 11, 2023 | Robert L Davidow | 10% Owner | Sell | $37K (264,000 @ $0.14) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.